2025-02-21 IDOPRESS
TOKYO,Feb. 20,2025 -- On February 20,the second day of the World Smart Energy Week exhibition in Japan,TAOKE ENERGY and CATL reached a battery procurement agreement with a total capacity of 300MWh. The batteries will be used for TAOKE ENERGY's grid-scale ESS projects during 2025. Since 2023,TAOKE ENERGY has been focused on the development and sales of high-voltage grid-scale ESS in Japan. As its ESS business in Japan continues to expand over the past two years,so following last year's 350MWh procurement contract,TAOKE ENERGY has once again reached a new procurement agreement with CATL this year.

TAOKE ENERGY And CATL Reached A 300MWh Battery Purchase Agreement
In recent years,grid-scale ESS has emerged as a rising star in Japan's new energy field,showing rapid development and attracting many investors,entrepreneurs and traders. TAOKE ENERGY's advantage lies in its early market layout,which has enabled it to seize this opportunity. Looking ahead,TAOKE ENERGY will continue to focus on providing diversified development solutions for grid-scale ESS in Japan.
So far,TAOKE ENERGY has successfully developed 24 grid-scale ESS projects in Japan,11 of which are self-invested. In the future,TAOKE ENERGY will adhere to multiple strategies of self-investment and joint investment on seeking more partners for in-depth cooperation and gain success together!
As the battery supplier for TAOKE ENERGY,CATL has kept providing safe and reliable products for years. While signing this agreement,CATL also made supportive commitments to TAOKE ENERGY in terms of pricing and delivery schedules. In the future,the two enterpriseswill further consolidate their win-win cooperative relationship,leverage their respective strengths,and jointly explore a broader market in Japan's new energy field!
Consulting Information:
Taoke Energy co.,ltd
Adress: 105-0012Komatsu building 3F,Shibadaimon1-11-4,Minato-ku,Tokyo,Japan
Tel.: 03-6452-8666
Email: sales@taoke-energy.com
HP:https://www.taoke-energy.com/
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
MEXC Claims Dual Wins at BeInCrypto 100 Awards as Best Centralized Exchange and Best Exchange in LATAM
©copyright 2009-2020 Singapore Info Map